Survival Rate Of Pancreatic Cancer
Pancreatic cancer is one of the most aggressive human malignancies, with a dismal survival rate of 12% and very few resources and tools to combat it. There is no simple pancreatic cancer screening test or other pancreatic cancer early detection tools, and its earliest symptoms are non-specific.
We recognize that there is a large gap between scientific discoveries made in the lab and effective treatments for patients. Up until now, there hasn’t been a lot of incentive for pharmaceutical companies to develop drugs for pancreatic cancer patients because it has been viewed as an uncommon cancer.
Both the incidence and mortality of pancreatic cancer are increasing, and it is projected to become the 2nd LEADING CAUSE of cancer-related deaths in the United States by 2030.
It’s estimated that 50% + of pancreatic cancer patients are diagnosed when the condition is already metastatic – meaning it has spread to other parts of the body. We’re working on changing that.
This staggering statistic is so high due to the unique location and structure of the pancreas. Tumors are generally not felt due to the positioning of the pancreas and the difficulty reaching it. Moreover, people generally only display pancreatic cancer symptoms when the tumor becomes large enough to interfere with other organs. Sadly, by this time, it’s often too late.
Does Donating To Cancer Research Help
Pancreatic Cancer is the deadliest common cancer, yet it receives less than 3% of cancer research funding. At TrovaNOW, our mission is to raise funding for collaborative research for pancreatic cancer early detection and prevention – the largest effort of its kind in the world.
We are an international, multi-institutional collaborative consortium of world renowned experts in pancreatic cancer that is assembling the largest high-risk patient cohort, with biospecimen collection and longitudinal clinical data. Pancreatic cancer early detection and prevention would dramatically change the trajectory of the disease, saving tens of thousands of lives each year.
Be a hero by donating today to pancreatic cancer research. Your support keeps pancreatic cancer research going. Contributions go towards:
- Maximizing identification of high risk individuals + advance early detection research and clinical care.
- Developing and validating an early detection blood test for pancreatic cancer.
- Advancing the understanding of genetics to pancreatic cancer risk and development, including finding new pancreatic cancer susceptibility genes.
- Formulating and executing a strategic plan for pancreatic cancer prevention.
Join us in our mission to advance pancreatic cancer early detection to transform the landscape of this disease and improve survival rates. Research and innovation are critical for creating breakthroughs that will improve the lives of pancreatic cancer patients.
Together we fight. For our family. For our friends. For the future. For all. At TrovaNow, we are up for the challenge. If you have any questions or If you want more information about how to donate, just email us at trovanow@gmail.com or learn more at http://trovanow.com
